CompletedNCT03142919
Inflammatory Challenge and Brain Responses in Major Depression
About this title
Read the official source — NCT03142919Placebo comparisonAges 18–55United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- TulsaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: September 7, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 64
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Sponsor type
- Research institute
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03142919
- Official title
Show the full official title
Response to Inflammatory Challenge in Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tulsa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
